Find a Clinical Trial

Filter

Services

Allergy

Allergy
Amyloidosis

Amyloidosis
Anesthesiology

Anesthesiology
Aortic Diseases + Aneurysms

Aortic Diseases + Aneurysms
Asthma

Asthma
Back + Neck Pain

Back + Neck Pain
Bladder Cancer

Bladder Cancer
Blood Disorders + Hematology

Blood Disorders + Hematology
Brain Tumor

Brain Tumor
Breast Cancer

Breast Cancer
Breast Surgery + Oncoplastics

Breast Surgery + Oncoplastics
Cancer

Cancer
Cancer + Hematology (Pediatrics)

Cancer + Hematology (Pediatrics)
Cardiac Sarcoidosis

Cardiac Sarcoidosis
Cardiac Surgery

Cardiac Surgery
Cardiology

Cardiology
Cardiology (Pediatrics)

Cardiology (Pediatrics)
Cardiovascular Care

Cardiovascular Care
Center for Children with Special Needs
Colon + Rectal Cancer

Colon + Rectal Cancer
Critical Care

Critical Care
Dentistry

Dentistry
Dermatology

Dermatology
Emergency Medicine (Pediatrics)

Emergency Medicine (Pediatrics)
Gastroenterology + Digestive Health

Gastroenterology + Digestive Health
Gastroenterology + Digestive Health (Pediatrics)
Gynecologic Cancer

Gynecologic Cancer
Gynecology (Pediatric + Adolescent)

Gynecology (Pediatric + Adolescent)
Head + Neck Cancer

Head + Neck Cancer
Heart Failure + Heart Transplant

Heart Failure + Heart Transplant
Hematologic Cancers

Hematologic Cancers
Hospital Medicine (Pediatrics)

Hospital Medicine (Pediatrics)
Infectious Diseases

Infectious Diseases
Inflammatory Bowel Disease (IBD)

Inflammatory Bowel Disease (IBD)
Kidney Function Evaluation

Kidney Function Evaluation
Lung Cancer

Lung Cancer
Maternal Fetal Medicine

Maternal Fetal Medicine
Multiple Sclerosis

Multiple Sclerosis
Myeloma + AL Amyloidosis

Myeloma + AL Amyloidosis
Nephrology

Nephrology
Nephrology (Pediatrics)

Nephrology (Pediatrics)
Neurology

Neurology
Neurosurgery

Neurosurgery
Newborn Medicine

Newborn Medicine
Obstetrics + Gynecology (OBGYN)

Obstetrics + Gynecology (OBGYN)
Obstetrics + Maternity

Obstetrics + Maternity
Ocular Melanoma

Ocular Melanoma
Ophthalmology (Pediatrics)

Ophthalmology (Pediatrics)
Ophthalmology + New England Eye Center
Orthopedics

Orthopedics
Orthopedics (Pediatrics)

Orthopedics (Pediatrics)
Orthopedic Trauma

Orthopedic Trauma
Osteoarthritis

Osteoarthritis
Otolaryngology — Head + Neck Surgery (Ear, Nose + Throat)
Pancreatic Cancer

Pancreatic Cancer
Pediatrics

Pediatrics
Prostate Cancer

Prostate Cancer
Psychiatry + Psychotherapy (Adult)

Psychiatry + Psychotherapy (Adult)
Pulmonary Hypertension

Pulmonary Hypertension
Pulmonology

Pulmonology
Radiation Oncology

Radiation Oncology
Rheumatoid Arthritis

Rheumatoid Arthritis
Rheumatology

Rheumatology
Spine Care

Spine Care
Stroke

Stroke
Stroke + Young Adults (SAYA)

Stroke + Young Adults (SAYA)
Surgery

Surgery
Thoracic Surgery

Thoracic Surgery
Trauma Surgery

Trauma Surgery
Tuberculosis + Other Mycobacterial Infections
Urology

Urology
Valvular + Structural Heart Health

Valvular + Structural Heart Health
Vascular Disease

Vascular Disease
Vascular Surgery

Vascular Surgery
Wound Healing

Wound Healing
Interventional Cardiology

Interventional Cardiology
Liver Disease

Liver Disease

Showing 1 - 4 out of 4

Allogenic Hepatocyte Transplantation into Periduodenal Lymph Nodes

A Phase 2a, Open Label, Dose Escalation Study for Safety, Tolerability, and Efficacy of Hepatocyte Transplantation Into Periduodenal Lymph Nodes Among Subjects With End-Stage Liver Disease

Liver diseases

All genders

18-70

Recruiting now

Department of Medicine, Division of Gastroenterology + Hepatology

Tufts Medical Center

Learn more

A multicenter trial assessing the impact of lipoprotein(a) lowering with pelacarsen (TQJ230) on the progression of calcific aortic valve stenosis

A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein(a) lowering with pelacarsen (TQJ230) on the progression of calcific aortic valve stenosis [Lp(a)FRONTIERS CAVS] Clinical

Aortic stenosis

All genders

50+

Recruiting now

Division of Cardiology

Tufts Medical Center

Learn more

The Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C)

Hepatology

All genders

18-70

Recruiting now

Department of Medicine, Division of Gastroenterology + Hepatology

Tufts Medical Center

Learn more

Voyage Study

VK2809 A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy, Safety, And Tolerability Of VK2809 Administered For 52 Weeks Followed By A 4-Week Off-Drug Phase In Subjects With Biopsy Proven Non-Alcoholic Steatohepatitis With Fibrosis

Non-alcoholic steato-hepatitis or fatty liver disease

All genders

18-75

Recruiting now

Department of Medicine, Division of Gastroenterology + Hepatology

Tufts Medical Center

Learn more

Language 1

Language 2

Language 3

Privacy on this site

We collect and process your data on this site to better understand how it is used. You can give your consent to all or selected purposes, or you can decline them all. For more information, see our privacy policy.

Analytics

Marketing automation

AnalyticsWe'll collect information about your visit to our site. It helps us understand how the site is used – what's working, what might be broken and what we should improve.

Marketing automationWe'll use your data to send you more relevant email or text message campaigns. We'll also use it to exclude you from campaigns that you might not like.

Find Care

Services + Treatments

Patients + Visitors

Research + Academics

Clinicians

Find a Clinical Trial

Filter

A Phase 2a, Open Label, Dose Escalation Study for Safety, Tolerability, and Efficacy of Hepatocyte Transplantation Into Periduodenal Lymph Nodes Among Subjects With End-Stage Liver Disease

A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein(a) lowering with pelacarsen (TQJ230) on the progression of calcific aortic valve stenosis [Lp(a)FRONTIERS CAVS] Clinical

The Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C)

VK2809 A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy, Safety, And Tolerability Of VK2809 Administered For 52 Weeks Followed By A 4-Week Off-Drug Phase In Subjects With Biopsy Proven Non-Alcoholic Steatohepatitis With Fibrosis